Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
903.3 DKK | -1.05% | +2.28% | +29.39% |
06:01am | Genetic profile may predict best response to weight-loss drug Wegovy | RE |
May. 17 | Roche: share price stands out, Deutsche Bank in support | CF |
ETFs positioned on Novo Nordisk A/S
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.56% | 1,166 M€ | +0.26% | - | |
0.56% | 607 M€ | +0.05% | - | |
0.47% | 205 M€ | -.--% | ||
0.43% | 242 M€ | +9.62% | ||
0.39% | 283 M€ | +20.97% | ||
0.29% | 391 M€ | +9.28% | - | |
0.26% | 0 M€ | 0.00% | - | |
0.24% | 34 M€ | +9.12% | - | |
0.18% | 306 M€ | +6.40% | - | |
0.18% | 39 M€ | +6.43% | - | |
0.17% | 20 M€ | +1.21% | - | |
0.15% | 105 M€ | +4.03% | - | |
0.13% | 34 M€ | +3.87% | - | |
0.12% | 17 M€ | +3.40% | - | |
0.09% | 234 M€ | +5.72% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.39% | 584B | |
+32.09% | 693B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B | |
-0.52% | 162B |
- Stock Market
- Equities
- NOVO B Stock
- Funds and ETFs Novo Nordisk A/S